Endocrinology

Top Story

Dual therapy ertugliflozin, sitagliptin improves glycemic control in type 2 diabetes

Dual therapy ertugliflozin, sitagliptin improves glycemic control in type 2 diabetes
January 22, 2018
In the Journals

ACA reduces out-of-pocket medical expenses

January 22, 2018
The implementation of the ACA reduced out-of-pocket spending for medical care, especially for low-income individuals; however, premium spending remained high for these…
In the Journals Plus

Infection risks may increase with type 1 diabetes

January 22, 2018
Compared with the general public, people with diabetes — and type 1 diabetes, in particular — have increased risks for serious infections, according to…
In the Journals Plus

Diabetes increases breast cancer mortality risk

January 22, 2018
Women with breast cancer and diabetes have a greater risk for all-cause and cancer-specific mortality and are less likely to receive chemotherapy and radiotherapy…

Report: BPS replaces BPA in many store receipts

January 21, 2018
An analysis of more than 150 store receipts revealed that most no longer contain the endocrine-disrupting chemical bisphenol A; however, many now contain bisphenol S…
More Headlines »
CME ABIM MOC

Ace the Case: A 57-Year-Old Woman who has Gained and Lost Weight

There is no commercial support for this activity.

This “Ace the Case” study will discuss the discuss the management of obesity in a 57-year old woman. Accurately assess…
More »
Video
Meeting News

VIDEO: Novel protein plus cold exposure promising for preventing obesity

October 31, 2017
More »
Resource Centers
ObesityWeek

ObesityWeek

CME

Rapid Response from Austin: Expanding Options in Type 2 Diabetes Management

This activity is supported by educational grants from Boehringer Ingelheim Pharmaceuticals, Inc. and Lilly USA, LLC.

Approximately 150 million people worldwide have diabetes mellitus and this number is expected to double by 2025…
More »
Current Issues
View the Current Issue